Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 1,008.00
-42.95 (-4.09%)
Jul 10, 2026, 3:29 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 51.36 billion as of July 10, 2026. Its market cap has increased by 47.94% in one year.
Market Cap
51.36B
Enterprise Value
54.15B
Revenue
8.11B
Ranking
n/a
PE Ratio
250.01
Stock Price
1,008.00
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 51.36B, an increase of 6,960.67%. That is a compound annual growth rate of 111.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 51.36B | 33.41% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 107.47B |
| Strides Pharma Science | 99.79B |
| Sudeep Pharma | 93.10B |
| Sun Pharma Advanced Research Company | 85.87B |
| Aarti Pharmalabs | 64.32B |
| Innova Captab | 56.62B |
| RPG Life Sciences | 47.25B |
| Solara Active Pharma Sciences | 27.41B |